3D bioprinting can help end organ transplant waitlists — if the FDA stops delaying
For 3D bioprinting technology to reach its full potential, billions of investment dollars will be needed. That will be possible only if the FDA provides clear, predictable rules and standards for this new area of medicine.
www.statnews.com